D.G.I.T Symposium Draws Strong Participation
Sharing Real-World Applications of Fundus Screening, CGM, and AI-Based Solutions

Experts at the D.G.I.T Symposium stated that digital healthcare technologies-such as AI-based fundus imaging analysis devices, continuous glucose monitors, and dietary data platforms-can significantly enhance the early diagnosis and chronic disease management capabilities of primary care institutions.


On December 12, Daewoong Pharmaceutical announced that it had held the '2025 D.G.I.T Symposium (Daewoong Global Innovation in Technology Symposium)' at the RYSE Hotel in Mapo-gu, Seoul, on the 29th of last month. The symposium was designed to allow healthcare professionals to explore the latest trends in digital health devices and their clinical applications through lectures and hands-on experience lounges, as well as to provide evidence necessary for decision-making regarding actual adoption.


Professor Jongjin Jung of Kim Eye Hospital is presenting at the D.G.I.T Symposium on the 29th of last month. Photo by Jongjin Jung

Professor Jongjin Jung of Kim Eye Hospital is presenting at the D.G.I.T Symposium on the 29th of last month. Photo by Jongjin Jung

View original image

During the symposium, lectures on the utilization of digital healthcare for more than 100 primary care physicians were held over two days. On the first day, Professor Jongjin Jung of Kim Eye Hospital presented on "The Role of Fundus Screening in Preventing Blinding Diseases," while Professor Byungwook Yoo of the Department of Family Medicine at Soonchunhyang University Seoul Hospital discussed "Smart Diabetes Management: CGM & Lifestyle Pattern Intervention in Clinical Practice," explaining the clinical utility of continuous glucose monitors and dietary data-based metabolic disease management.


On the second day, Dr. Chihoon Lee, Director of Cecil Internal Medicine Clinic, addressed "Chronic Disease Management Using Digital Health in Primary Care Settings," focusing on practical applications in clinic-level medical practice. Professor Hyunsook Jung of the Department of Family Medicine at Kangbuk Samsung Hospital presented "Advances and Clinical Applications of AI in Electrocardiography," outlining the direction of digital transformation in ECG analysis.


In his presentation on the first day, Professor Jongjin Jung of Kim Eye Hospital identified age-related macular degeneration, diabetic retinopathy, and glaucoma as the "three major blinding diseases," emphasizing the importance of early diagnosis. He stated, "Once vision loss occurs in these diseases, recovery is difficult and may lead to blindness, so it is crucial to detect them as early as possible."


Professor Byungwook Yoo of Soonchunhyang University Seoul Hospital further stressed that personalized management education, which takes into account individual lifestyle habits and metabolic capacity, is a core area where primary care institutions should actively intervene.

A medical staff member is experiencing an AI-based sarcopenia test at the '2025 D.G.I.T Symposium (Daewoong Global Innovation in Technology Symposium)' held at the RYSE Hotel in Mapo-gu, Seoul, on the 29th of last month. Daewoong Pharmaceutical

A medical staff member is experiencing an AI-based sarcopenia test at the '2025 D.G.I.T Symposium (Daewoong Global Innovation in Technology Symposium)' held at the RYSE Hotel in Mapo-gu, Seoul, on the 29th of last month. Daewoong Pharmaceutical

View original image

Professor Yoo explained, "The treatment of metabolic diseases begins with understanding all aspects of daily life, including dietary habits, activity patterns, and sleep." He particularly highlighted insulin sensitivity as a key indicator, saying, "Insulin sensitivity shows how well the body responds to insulin, and there is significant variation among individuals. Recently, with continuous glucose monitors, it is possible to monitor real-time blood glucose responses to changes in activity and diet, making it possible to meaningfully measure insulin sensitivity."


Meanwhile, the symposium strengthened its experience zone to reflect the needs of primary care settings. Digital devices for metabolic health and primary chronic disease management were added, allowing internal medicine and family medicine practitioners to experience the devices in workflows closely aligned with actual clinical practice.


Additionally, a "Digital Health Device Expert Academy" was held for nurses and nurse assistants, offering practical, work-focused training on device principles, usage, and patient counseling that can be immediately applied in clinical settings.



Park Hyungchul, Head of ETC Marketing at Daewoong Pharmaceutical, stated, "This year's lineup of speakers consisted of top-level experts in the industry, and the lectures clearly conveyed how digital healthcare can be utilized in the field. After the lectures, we operated an experience lounge to help each medical institution quickly assess the feasibility of actual adoption."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing